SCYX SCYNEXIS, Inc.

2.83
+0  (3%)
Previous Close 2.76
Open 2.83
Price To book 1.95
Market Cap 72.24M
Shares 25,527,000
Volume 493,914
Short Ratio 4.05
Av. Daily Volume 394,615

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Clinical hold placed on the initiation of intravenous (IV) SCY-078 until the FDA completes a review of all data. Clinical hold follows three mild-to-moderate thrombotic events in healthy volunteers - announced March 2, 2017. Meeting scheduled with FDA for 2Q 2017.
Intravenous SCY-078
Phase 2 data released June 2016. Full study results released October 2016.
SCY-078
Vulvovaginal candidiasis (VVC)
Phase 2 trial to be initiated 1Q 2017 with data due 4Q 2017.
SCY-078
Invasive candidiasis

Latest News

  1. APPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against SCYNEXIS, Inc. and Reminds Investors with Losses to Contact the Firm
  2. SCYX EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving SCYNEXIS, Inc. and a Lead Plaintiff Deadline of May 8, 2017
  3. APPROACHING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against SCYNEXIS, Inc. and Reminds Investors with Losses to Contact the Firm
  4. Eight Data Presentations at ECCMID Showcase the Broad Applicability of SCYNEXIS’ Lead Anti-infective Candidate SCY-078
  5. IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against SCYNEXIS, Inc. and Reminds Investors with Losses to Contact the Firm
  6. EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of SCYNEXIS, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 8, 2017 - SCYX
  7. EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against SCYNEXIS, Inc. and Reminds Investors with Losses to Contact the Firm
  8. SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in SCYNEXIS, Inc. of Class Action Lawsuit and Upcoming Deadline – SCYX
  9. SCYNEXIS to Host a Conference Call to Discuss Lead Anti-Infective Candidate SCY-078 Data Presented at 27th ECCMID
  10. INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against SCYNEXIS, Inc. and Reminds Investors with Losses to Contact the Firm
  11. SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In SCYNEXIS, Inc. To Contact The Firm Before Lead Plaintiff Deadline
  12. INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of SCYNEXIS, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 8, 2017 - SCYX
  13. SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against SCYNEXIS, Inc. (SCYX) and Lead Plaintiff Deadline - May 8, 2017
  14. EQUITY ALERT: Levi & Korsinsky, LLP Notifies Shareholders of SCYNEXIS, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 8, 2017 - SCYX
  15. INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against SCYNEXIS, Inc. and Reminds Investors with Losses to Contact the Firm
  16. SCYX LOSS NOTICE: Rosen Law Firm Reminds SCYNEXIS, Inc. Investors of Important Deadline in Class Action – SCYX
  17. DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In SCYNEXIS, Inc. To Contact The Firm
  18. The Klein Law Firm Announces the Commencement of a Class Action Filed on Behalf of SCYNEXIS, Inc. Shareholders and a Lead Plaintiff Deadline of May 8, 2017 (SCYX)
  19. INVESTOR ALERT: Goldberg Law PC Announces an Investigation of SCYNEXIS, Inc. and Encourages Investors with Losses to Contact the Firm
  20. SCYX INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving SCYNEXIS, Inc. and a Lead Plaintiff Deadline of May 8, 2017